Home Newsfeeds ‘Meta may launch a Quest 2 “Game Pass” for VR apps’ -Mixed Report

News

‘Meta may launch a Quest 2 “Game Pass” for VR apps’ -Mixed Report

https://mixed-news.com/en/meta-may-launch-a-quest-2-game-pass-for-vr-apps/

byBenzinga Newsdesk

March 6, 2023

1 minute read

https://mixed-news.com/en/meta-may-launch-a-quest-2-game-pass-for-vr-apps/

Rivian, Lucid, & Nikola Facing ‘EV Winter’ Challenge? Reportedly Struggling With Cost-Cutting Strategies To Boost Cash

By Nabaparna Bhattacharya

May 10, 1:37 PM

Rivian, Lucid, and Nikola implement cost-cutting strategies amid 'EV Winter,' facing challenges in the electric vehicle market, CNBC reports.

LCID

Accolade Q2 EPS $(0.66) Beats $(0.72) Estimate, Sales $87.60M Beat $82.86M Estimate

By Benzinga Newsdesk

October 6, 4:04 PM

Accolade (NASDAQ:ACCD) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.72) by 8.33 percent. This is a 31.96 percent increase over losses of $(0.97) per share from the same

ACCD

Call Of Duty 2025, Codenamed ‘Saturn,’ Is A Semi-Futuristic Sequel To Black Ops 2

By Franca Quarneti

December 21, 11:02 AM

The upcoming "Call of Duty" installment, codenamed 'Saturn' and referred to as Call of Duty 2025, will venture into a semi-futuristic setting, set to be a direct sequel to "Call of Duty: Black Ops 2. "

MSFT

Aytu BioPharma Announces Exclusive Agreement With Medomie Pharma Ltd. To Commercialize Adzenys XR-ODT And Cotempla XR-ODT In Israel And The Palestinian Authority

By Happy Mohamed

July 31, 8:06 AM

After the completion of local regulatory approvals, Aytu anticipates exporting to Medomie both of its novel, orally disintegrating, extended-release tablets for the treatment of ADHD ENGLEWOOD, CO and GIVATAYIM, ISRAEL

AYTU

‘Meta may launch a Quest 2 “Game Pass” for VR apps’ -Mixed Report

Related Posts

Rivian, Lucid, & Nikola Facing ‘EV Winter’ Challenge? Reportedly Struggling With Cost-Cutting Strategies To Boost Cash

Accolade Q2 EPS $(0.66) Beats $(0.72) Estimate, Sales $87.60M Beat $82.86M Estimate

Call Of Duty 2025, Codenamed ‘Saturn,’ Is A Semi-Futuristic Sequel To Black Ops 2

Aytu BioPharma Announces Exclusive Agreement With Medomie Pharma Ltd. To Commercialize Adzenys XR-ODT And Cotempla XR-ODT In Israel And The Palestinian Authority